ArticleThe oncologist2019

A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.

M Dror Michaelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.